Eversheds advises leading life sciences software firm on its sale to US company
Eversheds has advised US private equity firm Accel-KKR and the principal shareholders of Zinc Ahead on its sale to Veeva Systems for cash consideration of $130 million.
Zinc Ahead is a portfolio company of Accel-KKR, it is headquartered in Oxford, UK and has approximately 180 employees. Zinc is a leading provider of marketing compliance and approval software-as-a-service solutions to the life sciences industry. More than 50,000 marketing, medical and legal professionals currently use Zinc’s products across 120 clients in 170 countries.